Skip to main content
SpringerLink
Log in

Silencing of HPV 18 Oncoproteins With RNA Interference Causes Growth Inhibition of Cervical Cancer Cells

  • Original Articles
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Silencing the expression of human papillomavirus (HPV) oncoproteins should have therapeutic benefits for cervical cancer. The authors’ objective was to study RNA interference of the HPV 18 E6/E7 bicistronic mRNA with E6 small interfering RNA (siRNA) and E7 siRNA and determine the effect of each siRNA on oncoprotein expression, resultant cell growth, and downstream molecular effects. RNA interference was used to knockdown HPV 18 E6 and E7 oncoproteins on the HPV 18 positive cervical cancer cell lines HeLa and C4I. Western blotting was used to assay for each oncoprotein expression and select downstream molecular targets. Cell cycle analyses, cell viability assays, and colony formation assays were performed to determine the effect of treatment by both HPV 18 E6 siRNA and E7 siRNA. The transfection reagent oligofectamine and Tax siRNA were used as negative controls. Transfection with E6 siRNA caused complete loss of E6 but not E7 oncoprotein. However, E7 siRNA induced complete loss of both E6 and E7 oncoproteins. E6 siRNA mediated the reexpression of p53 protein and a moderate decrease in phosphorylated retinoblastoma protein expression (pRb), resulting in decreased colony formation. Transfection with E7 siRNA mediated a robust increase in p53 expression and complete loss of pRb, resulting in a marked decrease in colony formation compared to the E6 siRNA (P =.001). Flow cytometry revealed significantly increased apoptotic cells with E7 siRNA compared to E6 siRNA and control. RNA interference targeting the E7 portion of the bicistronic HPV 18 mRNA can silence both E6 and E7 oncoproteins and is most effective in cervical cancer growth inhibition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chakrabarti O, Krishna S. Molecular interactions of high risk human papillomaviruses E6 and E7 oncoproteins: implications for tumor progression. J Biosci. 2003;28:337–348.

    Article  CAS  Google Scholar 

  2. Pim D, Massimi P, Banks L. Alternatively spliced HPV 18 E6*protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth. Oncogene. 1997;15:257–264.

    Article  CAS  Google Scholar 

  3. Zur Hausen H. Papillomaviruses causing cancer: evasion from host cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92:690–698.

    Article  Google Scholar 

  4. Khan MJ, Castle PE, Lorinz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97:1072–1079.

    Article  Google Scholar 

  5. Corden SA, Sant-Cassia LJ, Easton AJ, Morris AG. The integration of HPV-18 DNA in cervical carcinoma. Mol Pathol. 1999;52:275–282.

    Article  CAS  Google Scholar 

  6. Thomas M, Pim D, Banks L. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene. 1999;18:7690–7700.

    Article  CAS  Google Scholar 

  7. Bedell MA, Jones KH, Laimens LA. The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3t3 and rat cells. J Virol. 1987;61:3401–3440.

    Article  Google Scholar 

  8. Herber R, Liem A, Pitot H, Lambert PF. Squamous and epithelial hyperplasia in mice transgenic for the human papillomavirus type 16 E7 oncogene. J Virol. 1996;70:1873–1881.

    Article  CAS  Google Scholar 

  9. Vousden K. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes. FASEB J. 1993;7:872–879.

    Article  CAS  Google Scholar 

  10. Alvarez-Salas LM, Cullinan AE, Siwkowski A, Hampel A, Dipaolo JA. Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes. Proc Natl Acad Sci U S A. 1998;95:1189–1194.

    Article  CAS  Google Scholar 

  11. Choo CK, Ling MT, Suen CKM, Chan KW, Kwong YL. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells. Gynecol Oncol. 2000;78:293–301.

    Article  CAS  Google Scholar 

  12. Venturini F, Braspenning J, Homann M, Gismann L, Sczakiel G. Kinetic selection of HPV 16 E6/E7 directed antisense nucleic acids: antiproliferative effect on HPV 16 transformed cells. Nucleic Acids Res. 1999:27:1585–1592.

    Article  CAS  Google Scholar 

  13. Scherer LJ, Rossi JJ. Approaches for the sequence-specific knockdown of mRNA. Nat Biotechnol. 2003;21:1457–1465.

    Article  CAS  Google Scholar 

  14. Sharp P. RNA interference—2001. Genes Dev. 2001;15:485–490.

    Article  CAS  Google Scholar 

  15. Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods. 2002;26:199–213.

    Article  CAS  Google Scholar 

  16. Chi J-T, Chang HY, Wang NN, Chang DS, Dunphy N, Brown PO. Genomewide view of gene silencing by small interfering RNAs. Proc Natl Acad Sci. 2003;100:6343–6346.

    Article  CAS  Google Scholar 

  17. Jiang M, Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene. 2002;21: 6041–6048.

    Article  CAS  Google Scholar 

  18. Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene. 2003;22:5938–5945.

    Article  CAS  Google Scholar 

  19. Hall AHS, Alexander KA. RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol. 2003;77:6066–6069.

    Article  CAS  Google Scholar 

  20. Sunaga N, Miyajima K, Suzuki M. Different roles for Caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Cancer Res. 2004;64:4277–4285.

    Article  CAS  Google Scholar 

  21. Jackson AL, Bartz SR, Schelter J, et al. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol. 2003;21:635–638.

    Article  CAS  Google Scholar 

  22. DeFilippis RA, Goodwin EC, Wu L, DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence and apoptosis in cervical carcinoma cells. J Virol. 2003;77:1551–1563.

    Article  CAS  Google Scholar 

  23. Kastan MB, Onyekwere O, Sidrasky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991;51:6304–6311.

    CAS  PubMed  Google Scholar 

  24. Jones DL, Munger K. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J Virol. 1997;71:2905–2912.

    Article  CAS  Google Scholar 

  25. Munger K, Basile JR, Duensing S, et al. Biological activities and molecular targets of the human papillomavirus E7 onco-protein. Oncogene. 2001;20:7888–7898.

    Article  CAS  Google Scholar 

  26. Bischof O, Nacerddine K, Dejean A. Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways. Mol Cell Biol. 2005;25:1013–1024.

    Article  CAS  Google Scholar 

  27. Mantovani F, Banks L, Mantovani F, Banks L, Mantovani F, Banks L, Mantovani F, Banks L, Mantovani F, Banks L, Mantovani F, Banks L, Mantovani F, Banks L, Mantovani F, Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene. 2001;20:7874–7887.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hamon Center of Therapeutic Oncology Research, J7. 124, Division of Gynecologic Oncology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9032, USA

    Jayanthi S. Lea MD, Noriaki Sunaga MD, Mitsuo Sato MD, Geetha Kalahasti MS, David S. Miller MD, John D. Minna MD & Carolyn Y. Muller MD

  2. University of New Mexico Health Sciences Center, Albuquerque, USA

    Jayanthi S. Lea MD, Noriaki Sunaga MD, Mitsuo Sato MD, Geetha Kalahasti MS, David S. Miller MD, John D. Minna MD & Carolyn Y. Muller MD

Authors
  1. Jayanthi S. Lea MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Noriaki Sunaga MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mitsuo Sato MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Geetha Kalahasti MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David S. Miller MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John D. Minna MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Carolyn Y. Muller MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jayanthi S. Lea MD.

Additional information

Supported in part by the Reproductive Scientist Development Program (National Institutes of Health 5K12HD00849).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lea, J.S., Sunaga, N., Sato, M. et al. Silencing of HPV 18 Oncoproteins With RNA Interference Causes Growth Inhibition of Cervical Cancer Cells. Reprod. Sci. 14, 20–28 (2007). https://doi.org/10.1177/1933719106298189

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719106298189

Key words

Search

Navigation